ClearBridge Investments
TXG icon

ClearBridge Investments’s 10x Genomics TXG Stock Holding History

ClearBridge Investments’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-424,704
Closed -$15.5M – 749
2022
Q4 		$15.5M Sell
424,704
-136,738
-24% -$4.47M 0.02% 464
2022
Q3 		$16M Sell
561,442
-399,208
-42% -$15.2M 0.02% 452
2022
Q2 		$43.5M Sell
960,650
-480,225
-33% -$24.9M 0.04% 340
2022
Q1 		$110M Buy
1,440,875
+322,493
+29% +$28.2M 0.08% 226
2021
Q4 		$167M Buy
1,118,382
+742,070
+197% +$114M 0.11% 175
2021
Q3 		$54.8M Buy
+376,312
New +$64.6M 0.04% 332

Other funds holding TXG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

ClearBridge Investments's TXG Position: Q1 2023 in Review

ClearBridge Investments sold out of 10x Genomics (TXG) in Q1 2023, closing a stake of 424,704 shares — an estimated $15.5M sold.

ClearBridge Investments first reported a position in TXG in Q3 2021 and held it in 6 quarters. The position peaked at $167M in Q4 2021. 258 funds tracked by Wall St. Rank hold TXG as of Q1 2023.

  • ClearBridge Investments reported no remaining 10x Genomics position as of Q1 2023 after selling out during the quarter.
  • ClearBridge Investments sold 424,704 10x Genomics shares in Q1 2023, an estimated $15.5M.
  • ClearBridge Investments first reported a position in 10x Genomics in Q3 2021 and held it in 6 quarters.
  • ClearBridge Investments's 10x Genomics position peaked at $167M in Q4 2021.
  • 258 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2023.

Based on ClearBridge Investments's 13F filing for Q1 2023, filed 12 May 2023.